Rheumatic Diseases  >>  dilmapimod (SB-681323)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dilmapimod (SB-681323) / GSK
NCT00134693 / 2004-005115-29: A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid Arthritis

Completed
2
77
Europe, RoW
Prednisolone, SB-681323
GlaxoSmithKline
Arthritis, Rheumatoid
08/06
08/06

Download Options